Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 123374
Published online Dec 14, 2026. doi: 10.3748/wjg.123374
Published online Dec 14, 2026. doi: 10.3748/wjg.123374
Table 6 Meta-analysis of inflammatory markers in active ulcerative colitis compared with clinical remission and healthy controls
| Number of studies | MD (95%CI) | I2 value | |
| FC levels | |||
| Active UC vs CR | 24 | 387.04 (292.55-481.54) | 99.90% |
| Active UC vs HCs | 11 | 486.94 (371.31-602.58) | 99.70% |
| ESR levels | |||
| Active UC vs CR | 42 | 14.33 (11.93-16.73) | 98.70% |
| Active UC vs HCs | 24 | 17.40 (13.42-21.38) | 99.50% |
| CRP levels | |||
| Active UC vs CR | 67 | 12.94 (10.48-15.41) | 99.40% |
| Active UC vs HCs | 38 | 16.81 (12.67-20.95) | 99.90% |
- Citation: Liu K, Zhang XH, Zhou XY, Liu YX, Pan SQ, Liu TX, Russell R, Wang XH, Yao YP, Zhao XJ, Sun HY, Ju CL, Liu JP, Liu ZL. Clinical features and biomarkers associated with ulcerative colitis: A systematic review and meta-analysis. World J Gastroenterol 2026; 32(46): 123374
- URL: https://www.wjgnet.com/1007-9327/full/v32/i46/123374.htm
- DOI: https://dx.doi.org/10.3748/wjg.123374